Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What additional medications were you taking at the time?

Was Gemfibrozil (Lopid) taken while taking Baycol?

Has Rhabdomyolysis been diagnosed?

Have any of the following side effects occurred?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Bayer Says Settlements Over Pulled Cholesterol Drug Total Nearly $1.1 Billion

Sep 20, 2004 | AP

Drug maker Bayer AG said Monday it has reached settlements in more than 2,800 cases related to the 2001 withdrawal of a cholesterol-lowering drug, paying nearly $1.1 billion in out-of-court deals.

Bayer pulled Lipobay, marketed as Baycol in the United States, after it was linked to a rare muscle-wasting syndrome and about 100 patient deaths.

In a regular update posted on its Web site, the Leverkusen-based company said it has now reached 2,861 settlements and agreed to pay a total of $1.094 billion without admitting liability. Some 7,577 suits are still pending, it said.

Earlier this year, Bayer reached an agreement with most of its insurers on coverage of around $1.2 billion for litigation related to the Lipobay withdrawal.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo